Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications

The gut commensal microbes modulate human immunity and metabolism through the production of a large number of metabolites, which act as signaling molecules and substrates of metabolic reactions in a diverse range of biological processes. There is a growing appreciation for the importance of immunome...

Full description

Bibliographic Details
Main Authors: Liuyun Zhang, Yunhui Xiang, Yanying Li, Juan Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1058272/full
_version_ 1811300647580991488
author Liuyun Zhang
Liuyun Zhang
Yunhui Xiang
Yunhui Xiang
Yanying Li
Yanying Li
Juan Zhang
author_facet Liuyun Zhang
Liuyun Zhang
Yunhui Xiang
Yunhui Xiang
Yanying Li
Yanying Li
Juan Zhang
author_sort Liuyun Zhang
collection DOAJ
description The gut commensal microbes modulate human immunity and metabolism through the production of a large number of metabolites, which act as signaling molecules and substrates of metabolic reactions in a diverse range of biological processes. There is a growing appreciation for the importance of immunometabolic mechanisms of the host-gut microbiota interactions in various malignant tumors. Emerging studies have suggested intestinal microbiota contributes to the progression of multiple myeloma. In this review, we summarized the current understanding of the gut microbiome in MM progression and treatment, and the influence of alterations in gut microbiota on treatment response and treatment-related toxicity and complications in MM patients undergoing hematopoietic stem cell transplantation (HSCT). Furthermore, we discussed the impact of gut microbiota-immune system interactions in tumor immunotherapy, focusing on tumor vaccine immunotherapy, which may be an effective approach to improve anti-myeloma efficacy.
first_indexed 2024-04-13T06:55:18Z
format Article
id doaj.art-bc0e3fdcd301470f94c81f49f58a64d8
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T06:55:18Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bc0e3fdcd301470f94c81f49f58a64d82022-12-22T02:57:17ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-12-011310.3389/fimmu.2022.10582721058272Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applicationsLiuyun Zhang0Liuyun Zhang1Yunhui Xiang2Yunhui Xiang3Yanying Li4Yanying Li5Juan Zhang6Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaSchool of Medicine, University of Electronic Science and Technology of China, Chengdu, ChinaDepartment of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, ChinaThe gut commensal microbes modulate human immunity and metabolism through the production of a large number of metabolites, which act as signaling molecules and substrates of metabolic reactions in a diverse range of biological processes. There is a growing appreciation for the importance of immunometabolic mechanisms of the host-gut microbiota interactions in various malignant tumors. Emerging studies have suggested intestinal microbiota contributes to the progression of multiple myeloma. In this review, we summarized the current understanding of the gut microbiome in MM progression and treatment, and the influence of alterations in gut microbiota on treatment response and treatment-related toxicity and complications in MM patients undergoing hematopoietic stem cell transplantation (HSCT). Furthermore, we discussed the impact of gut microbiota-immune system interactions in tumor immunotherapy, focusing on tumor vaccine immunotherapy, which may be an effective approach to improve anti-myeloma efficacy.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1058272/fullmultiple myelomagut microbiotahematopoietic stem cell transplantationimmune responsesvaccine immunotherapy
spellingShingle Liuyun Zhang
Liuyun Zhang
Yunhui Xiang
Yunhui Xiang
Yanying Li
Yanying Li
Juan Zhang
Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
Frontiers in Immunology
multiple myeloma
gut microbiota
hematopoietic stem cell transplantation
immune responses
vaccine immunotherapy
title Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
title_full Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
title_fullStr Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
title_full_unstemmed Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
title_short Gut microbiome in multiple myeloma: Mechanisms of progression and clinical applications
title_sort gut microbiome in multiple myeloma mechanisms of progression and clinical applications
topic multiple myeloma
gut microbiota
hematopoietic stem cell transplantation
immune responses
vaccine immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1058272/full
work_keys_str_mv AT liuyunzhang gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT liuyunzhang gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT yunhuixiang gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT yunhuixiang gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT yanyingli gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT yanyingli gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications
AT juanzhang gutmicrobiomeinmultiplemyelomamechanismsofprogressionandclinicalapplications